|
PIGS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08855155392484E-12 |
| Normal-vs-Stage2 |
3.1468050387673E-11 |
| Normal-vs-Stage3 |
1.33226762955019E-15 |
| Normal-vs-Stage4 |
1.62858615482264E-12 |
| Stage1-vs-Stage2 |
6.224400E-02 |
| Stage1-vs-Stage3 |
1.053610E-02 |
| Stage1-vs-Stage4 |
1.662200E-03 |
| Stage2-vs-Stage3 |
9.762200E-01 |
| Stage2-vs-Stage4 |
4.679800E-01 |
| Stage3-vs-Stage4 |
3.902400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.06360000001948E-06 |
| Normal-vs-Asian |
6.934000E-01 |
| Caucasian-vs-AfricanAmerican |
2.457800E-01 |
| Caucasian-vs-Asian |
1.790410E-01 |
| AfricanAmerican-vs-Asian |
1.565840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.30881980201048E-12 |
| Male-vs-Female |
1.294390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.15580000201876E-08 |
| Normal-vs-Age(41-60Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(61-80Yrs) |
1.65001345919791E-12 |
| Normal-vs-Age(81-100Yrs) |
4.19899999992701E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.461000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.646800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.276000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.047600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.528200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.639000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.310380E-02 |
| Normal-vs-Grade 2 |
1.38777878078145E-14 |
| Normal-vs-Grade 3 |
1.66755498298699E-12 |
| Normal-vs-Grade 4 |
1.63102864547682E-12 |
| Grade 1-vs-Grade 2 |
1.810440E-01 |
| Grade 1-vs-Grade 3 |
1.266030E-01 |
| Grade 1-vs-Grade 4 |
1.578390E-02 |
| Grade 2-vs-Grade 3 |
2.848600E-01 |
| Grade 2-vs-Grade 4 |
1.273680E-02 |
| Grade 3-vs-Grade 4 |
1.355000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.65156777143238E-12 |
| Normal-vs-ccB subtype |
6.51799725304159E-11 |
| ccA subtype-vs-ccB subtype |
4.829000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7732482149313E-12 |
| Normal-vs-N1 |
1.656370E-03 |
| N0-vs-N1 |
5.603600E-01 |
|
|
